Bioactive Abietane Diterpenoids from Salvia
J ournal of Natural Products, 2002, Vol. 65, No. 7 1019
Sch em e 4
EtOAc (4:1) to afford compound 4 (R
compound 5 (R ) 0.3, 15 mg).
f
) 0.7, 60 mg) and
f
Com p ou n d 1: pale yellow prisms, mp 45 °C; UV (MeOH)
max (log ꢀ) 243 (4.22), 335 (3.85) nm; IR (KBr) νmax 3442, 2958,
λ
-
1
1
13
1
678, 1633, 1458, 1377, 868 cm ; H and C NMR data, see
+
Tables 1 and 2; EIMS m/z 296 [M] (40), 268 (56), 253 (32),
28 (38), 225 (100), 185 (18); HREIMS m/z 296.1771 (calcd for
, 296.1776).
Com p ou n d 2: pale yellow powder; UV (CHCl
2
20 24 2
C H O
3
) λmax (log ꢀ)
3
1
33 (3.17), 358 (3.14), 374 (3.43) nm; IR (KBr) νmax 3435, 2953,
-
1 1
778, 1711, 1648, 1599, 1506, 1159, 1095, 959 cm ; H and
1
3
+
C NMR data, see Tables 1 and 2; EIMS m/z 270 [M] (84),
2
55 (100), 242 (31), 237 (20), 224 (6), 209 (10), 185 (17), 153
14 4
(16), 149 (30); HREIMS m/z 270.0905 (calcd for C16H O ,
2
70.0892).
Com p ou n d 3: yellow needles; mp 151-152 °C; UV (MeOH)
λ
max (log ꢀ) 260 (4.07) nm; IR (KBr) νmax 2964, 1716, 1643, 1627,
-
1
1
13
1
591, 1236, cm ; H and C NMR data, see Tables 1 and 2;
+
EIMS m/z 316 [M] (23), 301 (6), 298 (8), 283 (7), 272 (100),
57 (24), 229 (12), 216 (20), 203 (40); HREIMS m/z 316.2029
(calcd for C20 , 316.2038 ).
Oxid a tion of F er r u gin ol to Com p ou n d 3. Fremy’s salt
0.7 g) and KH PO (2.12 g, 15.6 mmol) were dissolved in water
60 mL). To this solution was added ferruginol (0.26 g, 0.91
2
at C-3 and C-4, respectively. Furthermore, only the hy-
droxyl group at C-3 could be oxidized to a carbonyl group.
Like compound 4, 5 is also a 4,5-seco-5,10-friedo-abietane
diterpenoid.
The bioactivities of compounds 1-5 have been tested.
Compound 3 displayed antimicrobial activity against the
Gram-positive organisms, Staphylococcus aureus and
Micrococcus luteus, when tested according to established
protocols17 (MIC values of 20.0 and 15.0 µM, respectively).
Compound 4 showed a significant inhibitory effect (IC50 0.8
28 3
H O
(
(
2
4
1
4
mmol) in 40 mL of acetone. The mixture was stirred in the
dark under N overnight. On concentration in vacuo, the
mixture was extracted with ether three times. The organic
2
phase was washed with water and brine, dried (MgSO ), and
4
evaporated. The residue was purified by flash chromatography
on a silica gel column (20 g) eluted with cyclohexane-EtOAc
(20:1) to give compound 3 (0.64 g, 83% yield).
Com p ou n d 4: red syrup, UV (MeOH) λmax (log ꢀ) 211 (4.48),
µM) on topoisomerase Ι according to a method developed
by Isabella et al.18 Compound 5 was evaluated for its
249 (4.47), 342 (3.57), 436 (3.25) nm; IR (film) ν
max 3390, 2930,
-
1
1
13
1
662, 1640, 1508, 1457, 1251, 1035 cm ; H and C NMR
cytotoxic activities against HL-60 human leukemia cells
and the SGC-7901 and MKN-28 stomach cancer cell lines
by a microculture tetrazolium colorimetric assay (MTT).19
This substance exhibited potent activities against the three
cancer cell lines with IC50 values of 4.6, 0.2, and 0.3 µM,
respectively. Compounds 1 and 2 were not found to be
active in any of these three assays.
+
data, see Table 3; EIMS m/z 314 [M] (3), 312 (28), 286 (5),
68 (7), 253 (3), 243 (100), 227 (10); HREIMS m/z 314.1825
calcd for C20 , 314.1882).
Acetyla tion of 4. A portion (20 mg, 0.064 mmol) of
compound 4 was dissolved in 2 mL of Ac O, and a trace amount
2
(
26 3
H O
2
of p-TsOH was added. The mixture was stirred at room
temperature with protection from light for 2 h. After the usual
workup, the reaction mixture was purified by preparative TLC
(
cyclohexane-EtOAc, 10:1; R ) 0.4) to afford 10 mg of 4a .
f
Exp er im en ta l Section
Compound 4a : red syrup, UV (MeOH) λmax (log ꢀ) 213 (3.81),
Gen er a l Exp er im en ta l P r oced u r es. The melting points
were determined on a Kofler hot-stage apparatus and are
uncorrected. UV spectra were measured on a Beckman DU-
220 (3.83), 247 (3.87), 407 (2.65), 443 (2.60) nm; IR (film) νmax
2860, 1732, 1662, 1433, 1367, 1256, 1175, 1020, 756 cm ; 1H
-1
+
NMR data, see Table 3; EIMS m/z 356 [M] (4), 298 (12), 296
(
36), 268 (36), 227 (100), 141 (14); HREIMS m/z 356.1993 (calcd
for C22 , 356.1988).
2
Syn th esis of 4 fr om Sa p r ior th oqu in on e. Hg(OAc) (190
6
00 spectrophotometer. IR spectra were measured on a Nicolet
1
13
28 4
H O
Magna 750 spectrophotometer. H, C, HMBC, and ROESY
1
NMR spectra were recorded on a Bruker AM-400 ( H) or a
1
3
mg, 0.50 mmol) was placed in a 50 mL round-bottomed flask,
and 5 mL of water together with 10 mL of THF were added,
followed by 150 mg of sapriorthoquinone11 (0.50 mmol). The
mixture was stirred at room temperature for 30 min. Then,
Bruker AC-100 ( C) spectrometer with TMS as internal
standard and CDCl as solvent. Mass spectra were obtained
3
on a MAT 711 mass spectrometer. Silica gel (200-300 mesh)
was used for column chromatography and silica gel GF254 for
preparative TLC.
0
.5 mL of a 3 M NaOH solution and 0.5 mL of 0.5 M NaBH
4
in a 3 M NaOH solution were added, and the reaction was
stopped immediately. After the usual workup, the crude
product was chromatographed by silica gel column chroma-
tography (cyclohexane-EtOAc, 7:1) to furnish 40 mg of
compound 4 (yield 20%).
P la n t Ma ter ia l. Salvia prionitis was collected at Yujiang,
J iangxi Province, People’s Republic of China, in J uly 1995, and
authenticated by Prof. X. L. Huang of our institute. A voucher
specimen is maintained in the Herbarium of Shanghai Insti-
tute of Materia Medica (SIMMP 95068).
Extr a ction a n d Isola tion . Dried roots of S. prionitis (5
kg) were extracted with EtOAc for 6 days at room temperature.
The solvent was removed in vacuo to yield 350 g of a gummy
residue. The extract was subjected to repeated chromatography
over silica gel eluted with mixture of cyclohexane-EtOAc of
increasing polarity (100:1 to 5:1). The fraction that eluted with
cyclohexance-EtOAc (30:1) was further chromatographed
using the same adsorbent and solvent system as presented
above to give 90 mg of compound 1 together with a mixture
containing compounds 2 and 3. This mixture was purified by
preparative TLC using cyclohexane-EtOAc (10:1) to afford
Com p ou n d 5: red syrup; UV (MeOH) λmax (log ꢀ) 353 (3.21),
435 (3.41) nm; IR (KBr) νmax 3487, 2966, 2936, 2872, 1709,
1689, 1659, 1633, 1568, 1464, 1254 cm ; H and C NMR
data, see Table 3; EIMS m/z 328 [M] (2), 316 (8), 286 (2), 270
(100), 242 (50), 228 (90), 224 (64), 200 (47); HREIMS m/z
-
1
1
13
+
328.1654 (calcd for C20
Syn th esis of Com p ou n d 5. To a stirred solution of
m-chloroperbenzoic acid (43 mg, 0.025 mmol) in CHCl (10 mL)
held at 0 °C was added a solution of sapriorthoquinone (60
mg, 0.02 mmol) dissolved in 6 mL of CHCl . The mixture was
stirred overnight at room temperature, washed with 10%
NaHCO solution, and dried over anhydrous MgSO . The
solvent was concentrated in vacuo, and the residue was
purified by silica gel column chromatography by elution with
cyclohexane-EtOAc (9:1) to afford epoxide 6 (50 mg, 79%
24 4
H O 328.1675).
3
1
1
3
3
4
compound 2 (R
f
) 0.4, 10 mg) and compound 3 (R
f
) 0.3, 15
mg). The fraction that eluted with cyclohexane-EtOAc (5:1)
was further purified by preparative TLC using cyclohexane-